Abstract
INTRODUCTION
Diabetes mellitus (DM) is a metabolic disorder which has a great impact worldwide. Diabetes mellitus is characterized by an elevation of blood glucose level caused by a relative or absolute de ciency of insulin. Type-2 DM may cause insulin resistance which can lead glucose accumulation in the circulation and consequently a hyperglycemic state, generating homeostatic and systemic imbalance. 3 Studies from 91 countries it is found that in 2010 there will be 285 million people worldwide with diabetes, with considerable disparity between populations and regions. It is also found that the pattern of diabetes varies considerably according to countries' economic status. For developed countries, the majority with diabetes are aged over 60 years, whereas for developing countries most people with diabetes are of working age, between 40 and 60 years. is di erence is likely to still be present in 2030. Population growth, ageing of populations and urbanization with associated lifestyle change is likely to lead to a 54% increase in worldwide numbers with diabetes by 2030. 1 Epidemiological data showed that in 2012 there were 371 million people a ected with the disease in the world, and it is estimated that in the year of 2030 we will have about 552 million diabetics. is worldwide prevalence a ects about 7% of the general population 2 . In Bangladesh prevalence of diabetes was found 9.2% in the year of 2013.
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According to International Diabetes Federation (IDF) Diabetes Atlas Seventh Edition, it is estimated that about 415 million adults aged 20-70 living with diabetes and 5.0 million deaths were attributed to diabetes globally in 2015. 19 According to WHO, diagnostic criteria of diabetes mellitus are fasting blood glucose≥ 7.0 mmol/l, 2 hrs after blood glucose ≥ 11.1mmol/l and HbA1 C ≥6.5%.
14 DM is a common disease, caused by many etiological factors and oxidative damage is one of the risk factors to play a major role in the pathogenesis of this disease. 4 High glucose level in diabetes inhibits G6PD expression and activity in endothelial cells, kidney, liver and RBCs, which leads to oxidative damage, cellular dysfunction and organ damage. is oxidative damage causes early destruction of RBCs which leads to anemia. e ROS, generated by hyperglycemia, causes many of the complications of diabetes, such as nephropathy, retinopathy, and neuropathy. Recent evidence indicated that oxidative damage markedly rose in type-2 diabetes mellitus. 6 Hyperglycemia has a direct relationship with the development of an in ammatory condition showed by the increased expression of pro-in ammatory cytokines. e elevation of pro-in ammatory cytokines plays an essential role in insulin resistance and induces the appearance of cardiovascular complications diabetic micro and macro vascular disease, kidney disease and anemia.
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According to Escorcio et al. by increasing pro-in ammatory cytokines, anti-erythropoietic e ect occurs, also promotes apoptosis of immature erythrocytes causing a decrease in the number of circulating erythrocytes and consequently causing a reduction of circulating hemoglobin. 22 Anemia represents an emerging global health problem that negatively impacts quality of life. 23 e anemic framework promotes reduced exercise capacity, fatigue, anorexia, depression, cognitive dysfunction, decreased libido, and other factors, which increase cardiac risk patients and depress the quality and life expectancy of the same.
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Some observer conducted a study to nd out the association between anemias with new onset diabetes. ey found that out of 1500 patients, 83 (5.5%) were anemic and 45 of the 83 patients were found to have identi able cause of anemia.
7 Again, some people (Meir (2003)) also observed the signs of hemolysis in diabetic subjects and they found decreased hemoglobin concentration, and increased reticulocyte count in them.
8 Some researchers (Ranil et al. (2010)) observed that the prevalence of anemia among the type 2 diabetes subjects was 12.3%. Similar study was made by Craig et al. (2005) . ey found that 8 of the 45 male diabetic patients (17.8%) were classi ed as anemic.
9; 10 A cross-sectional study was made by omas et Under these circumstances, anemia in patients with diabetes must be treated once diagnosed, since it may contribute to the pathogenesis and progression of cardiovascular disease and serious diabetic nephropathy and retinopathy. Anemia in diabetic person has a signi cant adverse e ect on quality of life and is associated with disease progression and the development of co-morbidities. e regular screening for anemia, along with other complications associated with diabetes, can help slowing the progression of vascular complications in those patients.
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MATERIALS AND METHODS
is cross sectional study was done in the department of Physiology in Dhaka Medical College Dhaka from January, 2011 to December 2011.Protocol of this study was approved by Ethical review committee of Dhaka Medical College and Diabetic Association of Bangladesh. For this study 60 male, age (40-60 years), diabetic subjects with FBG level ≥7.0 mmol/l and HbA 1 c ≥ 6.5 % and duration of diabetes > 3 years were selected from BIRDEM hospital. All the study subjects were on oral hypoglycemic drugs. irty healthy adult male were considered as control group for comparison. After selection of the subjects, the nature, purpose and bene t of the study were explained to each subject in details and were encouraged for voluntary participation. ey were also allowed to withdraw from the study whenever they feel like. Informed written consent was taken from the participants. Before taking blood, detailed family and medical history were taken. Anthropometric measurement of the subjects was done and blood pressure was measured. All the information's were recorded in a pre xed questionnaire. With aseptic precaution, 5 ml of venous blood was collected from ante-cubital vein by a disposable plastic syringe from each subject for estimation of HbA 1c, andFBG level was estimated in the laboratory of the Biochemistry Department of BIRDEM hospital and the G6PD tests were done in the laboratory of the Department of chemical biochemistry, AFIP, Dhaka Cantonment, Dhaka. All the parameters were expressed as mean ± SD (standard deviation). For statistical analysis was done by unpaired Student's t-test. P value < 0.05 was accepted as level of signi cance. Statistical analyses were performed by using a computer based statistical program SPSS (Statistical package for social science) Version 12.
RESULTS
A total number of 90 adult male subjects were selected for this study. Among them, 60 subjects were adult male with type 2 diabetes and 30 healthy subjects with same age range were selected as control group for comparison. e mean (±SD) FBG levels were 5.12 ±0.76, 7.48 ±1.27 and 9.14 ±2.10 mmol/L respectively in control subjects(group A), Controlled diabetes mellitus ( group B 1 )and Uncontrolled diabetes mellitus (group B 2 ). In this study, the mean (±SD) FBG level was signi cantly (p<0.0001) higher in group B 1 and group B 2 in comparison to that of group A. Again, FBG level was signi cantly (p<0.0001) higher in group B 2 than that of group B 1 . e mean (±SD) HbA 1c levels were 5.83±0.75, and 9.98 ±2.10 in group B 1 and B 2 respectively. In this study, the mean (± SD) HbA 1c level was signi cantly (p<0.0001) higher in group B 2 than that of group B 1 . (Table-I /L in groups A, B 1 and B 2 respectively. In this study, the mean RBC count was lower in group B 1 and group B 2 than that of group A. e mean RBC count in group B 2 was lower than that of group B 1 . In comparison to group A, it was signi cantly (p<0.003) lower in B 2 but non-signi cant in B 1 . e mean (± SD) reticulocyte count were 1.02 ±0.53, 1.49 ±0.93 and 2.26 ±0.99 % in group A, B 1 and B 2 respectively. In this study, the mean reticulocyte counts in di erent groups were within normal range. But the di erences of these mean values were signi cantly lower in group B 2 (p <0.0001) and in group B 1 (p <0.019) than group A. Within the study group reticulocyte count was signi cantly (p <0.003) higher in group B 2 than that of group B 1 . (Table-II) . ere are decreased values of Hb, hematocrit and red blood cells, which can be associated with a normocytic normochromic anemia, just like of an anemia of chronic disease. In mild to moderate anemia survival of red blood cells are decreases; it is about 80 days instead of 120 days.
is phenomenon is attributed to hyperactivity state mononuclear phagocyte system, triggered by infectious, in ammatory, or neoplastic process, leading to early removal of circulating red blood cells. 16 In the present study, early hemolysis is also observed in this study by decreased Hb%, RBC count and increased reticulocyte count.
e reticulocytosis may be due to compensatory response to hemolysis. And HbA 1 c test was done to assess their glycemic control, as HbA 1 c express the average amount of glucose in the last three month.
CONCLUSIONS
In this study, there are signi cant decrease in Hb conc., total count of RBC and increase in reticulocyte count in study groups. Nevertheless mean value of RBC and reticulocyte count were within normal range, but Hb conc. was below the normal limit. e prevalence of anemia is high in patients with type 2 DM.
is set of changes characterizes the anemia as chronic disease, which has a signi cant adverse e ect on quality of life of diabetic patients and this is associated with the progression of the disease; the development of co-morbidities signi cantly contributes to the increased risk of cardiovascular disease.
